Xopenex hfa and Cardiac disorder - a phase IV clinical study of FDA data

Summary:

Cardiac disorder is reported as a side effect among people who take Xopenex hfa (levalbuterol tartrate), especially for people who are female, 60+ old, also take Xopenex, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Cardiac disorder when taking Xopenex hfa. It is created by eHealthMe based on reports of 2,390 people who have side effects when taking Xopenex hfa from the FDA, and is updated regularly.

What is Xopenex hfa?

Xopenex hfa has active ingredients of levalbuterol tartrate. It is often used in asthma. eHealthMe is studying from 2,529 Xopenex hfa users. Check the latest studies of Xopenex hfa.

What is Cardiac disorder?

Cardiac disorder is found to be associated with 2,042 drugs and 1,960 conditions by eHealthMe. Check the latest studies of Cardiac disorder.

On Jul, 14, 2026

2,390 people reported to have side effects when taking Xopenex hfa.
Among them, 33 people (1.38%) have Cardiac disorder.

Could Xopenex hfa cause Cardiac disorder?

Among these 33 people:

What is the gender of people who have Cardiac disorder when taking Xopenex hfa? *

female: 83.87 %
male: 16.13 %

What is the age of people who have Cardiac disorder when taking Xopenex hfa? *

What are other drugs people take besides Xopenex hfa? *

What are other side effects people have besides Cardiac disorder? *

Sinusitis (inflammation of sinus): 12 people, 36.36%
Weight Decreased: 9 people, 27.27%
Arrhythmias (irregular heartbeat): 8 people, 24.24%
Dyspnea (difficult or laboured breathing): 8 people, 24.24%
Heart Rate Increased: 7 people, 21.21%
Staphylococcal Infection (an infection with staphylococcus bacteria): 6 people, 18.18%
Anaemia (lack of blood): 6 people, 18.18%
High Blood Pressure: 6 people, 18.18%
Post-Traumatic Stress Disorder: 5 people, 15.15%
Uveitis (inflammation of the uvea): 5 people, 15.15%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 16 people, 48.48%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 9 people, 27.27%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 8 people, 24.24%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 6.06%
Stress And Anxiety: 1 person, 3.03%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 3.03%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 3.03%
Cor Pulmonale Chronic (long lasting enlargement of the right ventricle of the heart): 1 person, 3.03%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 3.03%

* Approximation only. Some reports may have incomplete information.

Do you take Xopenex hfa and have Cardiac disorder?

- Check whether Cardiac disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Xopenex hfa:

Xopenex hfa (2,529 reports)

Cardiac disorder treatments and more:

Cardiac disorder (160,332 reports)

Browse all side effects of Xopenex hfa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cardiac disorder:

Cardiac disorder (2,042 drugs)

Browse all the conditions that are associated with Cardiac disorder:

Cardiac disorder (1,960 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on levalbuterol tartrate (the active ingredients of Xopenex hfa) and Xopenex hfa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.